On days 14–42, and on average:
· With hormonal therapy alone, 43 infants in 100 had spasms and 57 did not
· With hormonal therapy plus vigabatrin, 28 infants in 100 had spasms and 72 did notThanks Andy! The key words being "on average’ because of course it isn’t possible to say in advance whether an individual child will be better with one treatment or the other, or be helped with neither, or whether one, or both treatments may make things worse or even harm that individual. We do seem to be seeing a collective recognition that there is a huge difference between decision making for an individual and the evidence for a population. Both are needed of course, but the population-based evidence can only inform individual decision making, and does not dictate a policy to be applied to everyone, everywhere, all of the time. Modern decision making in medicine is steadily progressing towards consultations being a skilled, nuanced negotiation involving but not dominated by information - which is itself necessarily balanced by its validity and relevance (themselves involving some careful judgements).Great example Rohini. Thank you for posting.Best to allNealNeal MaskreyVisiting Professor of Evidence-informed decision making, Keele UniversityADVOCATE Field Studies, University of Amsterdam; a Horizon 2020 European Oral Health Project www.advocateoralhealth.comMobile: 07976276919
On 14 Jun 2018, at 13:18, Andy Hutchinson <[log in to unmask]> wrote:On days 14–42, and on average:· With hormonal therapy alone, 43 infants in 100 had spasms and 57 did not· With hormonal therapy plus vigabatrin, 28 infants in 100 had spasms and 72 did not
To unsubscribe from the EVIDENCE-BASED-HEALTH list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1= EVIDENCE-BASED-HEALTH&A=1
The information transmitted in this electronic communication, including all contents enclosed and/or attached, is intended only for the person or entity to whom it is addressed and may contain material that is confidential, privileged or otherwise protected from disclosure. Any review, re-transmission, copy, disclosure, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited. If you received this information in error, please contact the sender and properly destroy this communication and all copies thereof.
To unsubscribe from the EVIDENCE-BASED-HEALTH list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=EVIDENCE-BASED-HEALTH&A=1